Add the specialty areas of your choice to tailor excemed.org to your professional interests.
Save & Create free account
No thanks, just apply selection
I already have an account. Login

User login

We offer our registered users tailored information, free online courses and exclusive content.

Can't find your password?
Reset it here.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

IVF Preceptorship London

IVF Preceptorship London
  • Reproductive medicine
Preceptorship by Excemed
Friday, Sep 5 - Saturday, Sep 6 2014
London, United Kingdom

Accreditation

EACCME®

Event format

Course
Registration status
Closed

Overview

This Preceptorship is dedicated to providing new insights on hot topics in reproductive medicine through an interactive programme where each lecture is followed by specific case studies. This structure equips participants with up-to-date knowledge and the opportunity to share their experiences with peers and speakers. The live educational course will focus on Polycystic Ovary Syndrome (PCOS), controlled ovarian stimulation, recurrent implantation failure and new laboratory techniques and equipment for the optimization of IVF procedures.

Learning objectives

By attending this live educational course, learners will:

• Be updated on the main aspects of PCOS and the management of PCOS patients undergoing COS

• Apply the evidence-based recommendations to achieve the best management in poor and hyper responder patients

• Identify the best strategies for preventing OHSS

• Recognise the best genetic and laboratory techniques and adjuvant treatment protocols to improve implantation potential and endometrial receptivity

Accreditation details

EXCEMED (www.excemed.org) is accredited by the European Accreditation Council for Continuing Medical Education (EACCME ® ) to provide  the  following  CME  activity  for  medical  specialists.  The  EACCME ® is  an  institution  of  the  European  Union  of  MedicalSpecialists (UEMS), www.uems.net

The CME course IVF Preceptorship London held on 5-6 September 2014 in London, UK, is designated for a maximum of 9 (nine) hours of European CME credits (ECMEC). Each medical specialist should claim only those credits that he/she  actually  spent  in  the  educational  activity.  EACCME ® credits  are  recognized  by  the  American  Medical  Association  (AMA)towards the Physician's Recognition Award (PRA). To convert EACCME ® credit to AMA PRA category 1 credit, please contact the AMA.

 

 

EXCEMED adheres to the principles of the Good CME Practice Group (gCMEp).

Scientific programme

Friday, 5 September

 

Session I Stimulation protocols and management of complications

 

Chairs:  R. Fischer (Germany) - S. Lavery (UK)

09.15 L1:  Biomarkers predicting the extremes of ovarian response  

A. La Marca (Italy)

09.35 Number of oocytes and live births in IVF treatments

S.K. Sunkara (UK)

09.55 Poor and hyper responders: what is the best approach? 

A. La Marca (Italy)

11.15 WG1: Case study session on L3

Poor and hyper responders: what is the best approach?

A. La Marca (Italy)

 

Session II PCOS and luteal phase support

 

Chairs:  R. Fischer (Germany) - S. Lavery (UK)

13.15 Etiology and pathophysiology of PCOS patients and new diagnostic tools

R. Homburg (UK)

13.35 PCOS syndrome infertility management and  pregnancy outcome 

S.K. Sunkara (UK)

13.55 L6: Different options for luteal phase support

T. Child (UK)

15.00 WG2: Case study session on L4 and L5

Etiology and pathophysiology of PCOS patients

R. Homburg (UK)

PCOS syndrome: new diagnostic tools, infertility and pregnancy complications, laboratory and clinical outcomes

S.K. Sunkara (UK)

 

Saturday, 6 September

 

Session III Implantation failure: from biological aspects to laboratory techniques

 

Chairs:  R. Fischer (Germany) - S. Lavery (UK)

09.00 L7: Can different ovarian stimulation protocols affect oocyte and embryo morphology and quality?
P. Humaidan (Denmark)

09.20 PGD and PGS: indications, techniques and future perspectives
A. Capalbo (Italy)

09.40 Challenges to improve endometrial receptivity and implantation failure
R. Fanchin (France)

11.00 WG3: Case study session on L7 and L9

Can different ovarian stimulation protocols affect oocyte and embryo morphology and quality?
P. Humaidan (Denmark)

Challenges to improve endometrial receptivity and implantation failure
R. Fanchin (France)

Chair(s)

Stuart Lavery

IVF Hammersmith
Hammersmith Hospital
London, United Kingdom

Faculty

EXCEMED adheres to guidelines of the European Accreditation Council for Continuing Medical Education (EACCME®) and all other professional organizations, as applicable, which state that programmes awarding continuing education credits must be balanced, independent, objective, and scientifically rigorous. Investigative and other uses for pharmaceutical agents, medical devices, and other products (other than those uses indicated in approved product labeling/package insert for the product) may be presented in the programme (which may reflect clinical experience, the professional literature or other clinical sources known to the presenter). We ask all presenters to provide participants with information about relationships with pharmaceutical or medical equipment companies that may have relevance to their lectures. This policy is not intended to exclude faculty who have relationships with such companies; it is only intended to inform participants of any potential conflicts so that participants may form their own judgements, based on full disclosure of the facts. Further, all opinions and recommendations presented during the programme and all programme-related materials neither imply an endorsement nor a recommendation on the part of EXCEMED. All presentations represent solely the independent views of the presenters/authors.

The following faculty provided information regarding significant commercial relationships and/or discussions of investigational or non-EMEA/FDA approved (off-label) uses of drugs:

Antonio Capalbo Declared receipt of grants for fertility innovation.

Tim Child Declared receipts of grants and contracts from MRC. He is member of a company advisory board, board of directors or other similar group: Repin B.V.

Renato Fanchin Declared receipt of honoraria and consultation fees from Merck Serono.

Robert Fischer Declared no potential conflict of interest.

Roy Homburg Declared no potential conflict of interest.

Antonio La Marca Declared receipt of honoraria or consultation fees from Roche, MSD, Ferring, IBSA, Merck Serono.

Stuart Lavery Declared receipt of honoraria or consultation fees from Ferring and Merck Serono. He declared also receipt of grants and research support from Imperial College and Merck Serono.

The following faculty have provided no information regarding significant relationship with commercial supporters and/or discussion of investigational or non-EMEA/FDA approved (off-label) uses of drugs as of 25 August 2014.

Peter Humaidan

Sesh Kamal Sunkara

Publication
Reproductive medicine
Slide kit
Antonio Capalbo
Reproductive medicine
Slide kit
Renato Fanchin
Reproductive medicine
Slide kit
Antonio La Marca
Reproductive medicine
Slide kit
Sesh Kamal Sunkara
Reproductive medicine
Slide kit
Sesh Kamal Sunkara
Reproductive medicine